GSK’s messenger RNA vaccine for seasonal influenza is designed to prompt an immune response to two proteins on the surface of ...

Cushla and Clirinx, two Irish startups, are merging to give rare disease patients one continuous health and research record.

HHS awarded $77 million in SAMHSA grants for substance use prevention and treatment, mental health, suicide prevention and ...

Takeda Pharmaceutical’s Mimrylo is now approved for treating polycythemia vera, a rare blood cancer with limited therapeutic ...

A new report found that while more than 90% of health systems have deployed third-party AI tools, less than half have the ...

Roivant Sciences subsidiary Priovant Therapeutics received FDA approval for Lisraya as a treatment for the rare inflammatory ...

Onos Health's Series A funding round was led by Costanoa, with support from Flare Capital Partners and CVS Health Ventures.

AstraZeneca and Amgen drug Tezspire met the goals of a Phase 3 test in eosinophilic esophagitis (EoE), a chronic disorder ...

When the healthcare system defaults to uncertainty, people delay care because it feels safer for their wallets. In some cases ...

Biohaven is outlicensing to SK Biopharmaceuticals global rights to opakalim, a Kv7-targeting small molecule in pivotal ...

In this episode, we’re joined by Amanda Shafton, practicing CNM and national director of midwifery at Ob Hospitalist Group.

FDA approval of Revolution Medicines’ daraxonrasib, brand name Rasonque, makes the molecule the first RAS inhibitor approved ...